390 results on '"Kitchener, Henry C"'
Search Results
2. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
3. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
4. Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative
5. 3408: Ten-year results of the PORTEC-3 trial: adjuvant therapy for women with high-risk endometrial cancer
6. PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility Study
7. Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies
8. Working together to shape the endometrial cancer research agenda: The top ten unanswered research questions
9. Table S1 from PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility Study
10. Supplementary Materials from Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis
11. Supplementary table 1 from PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial
12. Supplementary Data from PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial
13. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
14. Lymphadenectomy in Endometrial Cancer: The Controversy Rages Unabated
15. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
16. Ovarian cancer
17. Urine testing for HPV
18. Cervical Cancer: A Global Health Crisis
19. Developing role of HPV in cervical cancer prevention
20. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial:Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
21. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
22. Body mass index does not influence post-treatment survival in early stage endometrial cancer: Results from the MRC ASTEC trial
23. Automation-assisted versus manual reading of cervical cytology (MAVARIC): a randomised controlled trial
24. The role of human papillomavirus in the genesis of cervical cancer
25. A prospective study of anal cancer screening in HIV-positive and negative MSM
26. Mortality Associated with Oral Contraceptive Use
27. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
28. Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial
29. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
30. Informing adolescents about human papillomavirus vaccination: What will parents allow?
31. Randomised Trial Comparing Hysterectomy With Endometrial Ablation For Dysfunctional Uterine Bleeding: Psychiatric And Psychosocial Aspects
32. PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility Study
33. The modern management of endometrial cancer
34. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
35. Lymphadenectomy in Endometrial Cancer: The Controversy Rages Unabated
36. Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on prognosis and benefit from adjuvant therapy
37. Adjuvant Radiotherapy for Stage I Endometrial Cancer: An Updated Cochrane Systematic Review and Meta-analysis
38. Chapter 7: Achievements and limitations of cervical cytology screening
39. Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes
40. Prophylactic HPV vaccination: current status
41. Screening post vaccination
42. Sexual Behavior and HPV Infection in British Women, by Postal Questionnaires and Telephone Interviews
43. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome
44. New Strategies in Cervical Screening
45. A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening
46. Post-menopausal bleeding
47. No alteration in NK function or ζ chain expression in NK and T cells of cervical cancer patients
48. The role of human papillomavirus in the genesis of cervical cancer
49. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3) : final results of an international, open-label, multicentre, randomised, phase 3 trial
50. Preferences for interventions designed to increase cervical screening uptake in non‐attending young women: How findings from a discrete choice experiment compare with observed behaviours in a trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.